No matter how well viruses are beaten back by modern-day medicines, tiny pools remain that can reemerge. Consider startup Agenovir Corp. the lifeguard that forces everyone out of the pool.
At least that's what the South San Francisco company aspires to do, using the highly touted, DNA-snipping CRISPR-Cas9 technology to create topical treatments targeting immune system-weakening cytomegalovirus, cervical cancer-causing human papillomavirus and other viral infections.
The company — the latest in…
No matter how well viruses are beaten back by modern-day medicines, tiny pools remain that can reemerge. Consider startup Agenovir Corp. the lifeguard that forces everyone out of the pool.
At least that's what the South San Francisco company aspires to do, using the highly touted, DNA-snipping CRISPR-Cas9 technology to create topical treatments targeting immune system-weakening cytomegalovirus, cervical cancer-causing human papillomavirus and other viral infections.
The company — the latest in…